155 related articles for article (PubMed ID: 32655395)
1. Chlorogenic Acid Decreases Malignant Characteristics of Hepatocellular Carcinoma Cells by Inhibiting DNMT1 Expression.
Liu Y; Feng Y; Li Y; Hu Y; Zhang Q; Huang Y; Shi K; Ran C; Hou J; Zhou G; Wang X
Front Pharmacol; 2020; 11():867. PubMed ID: 32655395
[TBL] [Abstract][Full Text] [Related]
2. Chlorogenic acid inhibits hepatocellular carcinoma in vitro and in vivo.
Yan Y; Liu N; Hou N; Dong L; Li J
J Nutr Biochem; 2017 Aug; 46():68-73. PubMed ID: 28458139
[TBL] [Abstract][Full Text] [Related]
3. Dulcitol suppresses proliferation and migration of hepatocellular carcinoma via regulating SIRT1/p53 pathway.
Lin XL; Li K; Yang Z; Chen B; Zhang T
Phytomedicine; 2020 Jan; 66():153112. PubMed ID: 31786318
[TBL] [Abstract][Full Text] [Related]
4. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
Xing Y; Liu Y; Qi Z; Liu Z; Wang X; Zhang H
Cell Mol Biol Lett; 2021 Nov; 26(1):49. PubMed ID: 34837962
[TBL] [Abstract][Full Text] [Related]
5. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
[TBL] [Abstract][Full Text] [Related]
6. Circ_0091581 Promotes the Progression of Hepatocellular Carcinoma Through Targeting miR-591/FOSL2 Axis.
Ji C; Hong X; Lan B; Lin Y; He Y; Chen J; Liu X; Ye W; Mo Z; She Z; Lin S
Dig Dis Sci; 2021 Sep; 66(9):3074-3085. PubMed ID: 33040214
[TBL] [Abstract][Full Text] [Related]
7. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
Li Q; Wang C; Wang Y; Sun L; Liu Z; Wang L; Song T; Yao Y; Liu Q; Tu K
J Exp Clin Cancer Res; 2018 Sep; 37(1):231. PubMed ID: 30231922
[TBL] [Abstract][Full Text] [Related]
8. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
9. HOTAIR-mediated reciprocal regulation of EZH2 and DNMT1 contribute to polyphyllin I-inhibited growth of castration-resistant prostate cancer cells in vitro and in vivo.
Xiang S; Zou P; Tang Q; Zheng F; Wu J; Chen Z; Hann SS
Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):589-599. PubMed ID: 29221985
[TBL] [Abstract][Full Text] [Related]
10. Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases.
Yan Y; Li J; Han J; Hou N; Song Y; Dong L
Anticancer Drugs; 2015 Jun; 26(5):540-6. PubMed ID: 25714249
[TBL] [Abstract][Full Text] [Related]
11. The RNA-binding protein SORBS2 suppresses hepatocellular carcinoma tumourigenesis and metastasis by stabilizing RORA mRNA.
Han L; Huang C; Zhang S
Liver Int; 2019 Nov; 39(11):2190-2203. PubMed ID: 31365778
[TBL] [Abstract][Full Text] [Related]
12. Uvangoletin, extracted from Sarcandra glabra, exerts anticancer activity by inducing autophagy and apoptosis and inhibiting invasion and migration on hepatocellular carcinoma cells.
Shen J; Zhu X; Wu Z; Shi Y; Wen T
Phytomedicine; 2022 Jan; 94():153793. PubMed ID: 34736000
[TBL] [Abstract][Full Text] [Related]
13. MiR-451a suppresses cell proliferation, metastasis and EMT via targeting YWHAZ in hepatocellular carcinoma.
Wei GY; Hu M; Zhao L; Guo WS
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5158-5167. PubMed ID: 31298411
[TBL] [Abstract][Full Text] [Related]
14. Expression of the lysyl oxidase propeptide in hepatocellular carcinoma and its clinical relevance.
Zheng Y; Wang X; Wang H; Yan W; Zhang Q; Chang X
Oncol Rep; 2014 Apr; 31(4):1669-76. PubMed ID: 24573150
[TBL] [Abstract][Full Text] [Related]
15. Hint1 suppresses migration and invasion of hepatocellular carcinoma cells in vitro by modulating girdin activity.
Wu XS; Bao TH; Ke Y; Sun DY; Shi ZT; Tang HR; Wang L
Tumour Biol; 2016 Nov; 37(11):14711-14719. PubMed ID: 27623945
[TBL] [Abstract][Full Text] [Related]
16. Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1.
Wei JC; Meng FD; Qu K; Wang ZX; Wu QF; Zhang LQ; Pang Q; Liu C
Acta Pharmacol Sin; 2015 Feb; 36(2):241-51. PubMed ID: 25557114
[TBL] [Abstract][Full Text] [Related]
17. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9.
Liu J; Wen X; Liu B; Zhang Q; Zhang J; Miao H; Zhu R
Mol Med Rep; 2016 Mar; 13(3):2401-8. PubMed ID: 26847170
[TBL] [Abstract][Full Text] [Related]
18. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
19. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
20. [Cannabinoid WIN55, 212-2 inhibits proliferation, invasion and migration of human SMMC-7721 hepatocellular carcinoma cells].
Wang J; Deng Y; Tan Y; Li K; Wen B; Zhao Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 May; 32(5):619-24. PubMed ID: 27126940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]